Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer is a research paper published in Redox Biology (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 014195
NCI NIH HHS
Grant: P01 CA265762
NCI NIH HHS
Grant: P30 CA014195
Heart Research Institute
Paul M Angell Family Foundation
David C Copley Foundation
Lustgarten Foundation
MeSH Terms
Keywords